RNA-targeting – Talk Bio

Actionable Insights Powered by AI

Merck KGaA and Skyhawk Therapeutics Launch $2B RNA-Targeting Neurology Collaboration

3 weeks ago talkbio0Tagged Billion Collaboration, Drug Development, Merck KGaA, milestone payments, nervous system disorder, RNA-targeting, royalties, Skyhawk, SkySTAR platform

Merck KGaA; Skyhawk Therapeutics; RNA-targeting; SkySTAR platform; neurological disorders; $2 billion collaboration; drug development; milestone payments; royalties

BioMarin and CAMP4 Collaborate on RNA-Targeting Therapies for Rare Genetic Diseases

11 months ago talkbio0Tagged Antisense, ASOs, BioMarin, CAMP4, genetic conditions, Hereditary Diseases, Oligonucleotides, regulatory RNA, RNA-targeting, Technology Platform

BioMarin, CAMP4, RNA-targeting therapies, genetic diseases, regulatory RNA, RAP Platform, antisense oligonucleotides, ASOs, rare genetic conditions